All terms in GO

Label Id Description
response to gemcitabine GO_0036272 [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gemcitabine stimulus. Gemcitabine is a 2'-deoxycytidine having geminal fluoro substituents in the 2'-position, and is used as a drug in the treatment of various carcinomas.]
obsolete negative regulation of methylenetetrahydrofolate reductase (NAD(P)H) activity GO_1903869 [OBSOLETE. Any process that stops, prevents or reduces the frequency, rate or extent of methylenetetrahydrofolate reductase (NAD(P)H) activity.]
response to methylphenidate GO_0036271 [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a methylphenidate stimulus.]
regulation of methylenetetrahydrofolate reductase (NAD(P)H) activity GO_1903868 [Any process that modulates the frequency, rate or extent of methylenetetrahydrofolate reductase (NAD(P)H) activity.]
response to diuretic GO_0036270 [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a diuretic stimulus. A diuretic is an agent that promotes the excretion of urine through its effects on kidney function.]
dihydrofolic acid binding GO_0051871 [Binding to dihydrofolic acid, a folic acid in which the bicyclic pteridine structure is in the dihydro, partially reduced form; they are intermediates in folate metabolism and are reduced to their tetrahydro, reduced forms.]
methotrexate binding GO_0051870 [Binding to methotrexate, an antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of tetrahydrofolate reductase and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA.]
response to 5-fluorouracil GO_0036275 [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a 5-fluorouracil stimulus.]
response to lapatinib GO_0036274 [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lapatinib stimulus.]
response to statin GO_0036273 [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a statin stimulus. Statins are organooxygen compounds whose structure is related to compactin (mevastatin) and which may be used as an anticholesteremic drug due its EC:1.1.1.34/EC:1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitory properties.]
pigment granule aggregation in cell center GO_0051877 [The directed movement of dispersed pigment granules towards the center of the cell.]
pigment granule dispersal GO_0051876 [The directed movement of pigment granules within a cell towards the cell periphery.]
Hsp90 protein binding GO_0051879 [Binding to Hsp90 proteins, any of a group of heat shock proteins around 90kDa in size.]
lateral element assembly GO_0051878 [The cell cycle process in which lateral elements are formed. Axial elements form a proteinaceous core between the two sister chromatids of each chromosome; the two axial elements then connect along their entire lengths by fine fibers known as transverse filaments, forming the lateral elements.]
sphingosine catabolic process GO_0051872 [The chemical reactions and pathways resulting in the breakdown of sphingosine (sphing-4-enine), trans-D-erytho-2-amino-octadec-4-ene-1,3-diol, a long chain amino diol sphingoid base that occurs in most sphingolipids in animal tissues.]
sphinganine-1-phosphate catabolic process GO_0051874 [The chemical reactions and pathways resulting in the breakdown of sphinganine-1-phosphate, the phosphorylated derivative of D-erythro-2-amino-1,3-octadecanediol.]
sphinganine-1-phosphate metabolic process GO_0006668 [The chemical reactions and pathways involving sphinganine-1-phosphate, the phosphorylated derivative of D-erythro-2-amino-1,3-octadecanediol.]
obsolete positive regulation of methylenetetrahydrofolate reductase (NAD(P)H) activity GO_1903870 [OBSOLETE. Any process that activates or increases the frequency, rate or extent of methylenetetrahydrofolate reductase (NAD(P)H) activity.]
striated muscle paramyosin thick filament assembly GO_0061203 [The aggregation, arrangement and bonding together of proteins to form the paramyosin-based thick filaments of myofibrils in striated muscle.]
paramyosin filament assembly or disassembly GO_0061204 [The formation or disassembly of a filament composed of paramyosin molecules.]